
price
maintain posit rate dd
lower price target reflect
reduct forecast lower
expect transact price busi
dupont share mute reaction monet nutrit bioscienc
 divis via rmt ebitda transact valuat
line slightli market expect integr concern elev net debt level
post rmt concern well reflect share price declin post
deal-announc dd reiter guidanc note
one-tim earn benefit reoccur
dd busi ev combin entiti ev
base share price cours move target share
declin sinc transact announc dd sharehold
share combin compani dd receiv one-tim cash
payment subject certain adjust upon deal estim close
manag expect limit amount anti-trust issu portfolio
minim overlap combin compani expect gener pro-forma
revenu excess ebitda target adjust ebitda
margin pre-synergi post cost synergi
continu next page
realiz cost synergi china/usa tariff resolut execut non-cor divestitur
recessionari downsid risk assum discount ebitda
discount multipl
susquehanna intern group llp compris affili entiti includ susquehanna financi group lllp sfg sfg provid research execut
servic sfg member finra sfg seek busi compani cover research report result investor awar firm may
conflict interest could affect object report pleas see import disclosur page
continu previou page
compellingstrategiclog ceo andrea fibig note transact predic upon achiev
scale rather focus combin complementari product portfolio offer custom uniqu formul
achiev first-mov advantag food beverag health well home person care end-
market current run combin expect signific sourc synergi
prove meaning competit advantag term product innov dd ceo ed breen
note closest peer spend half amount next three player spend closer
one-third target run-rat cost synergi within three year transact close
come procur streamlin overhead manufactur effici revenu
synergi year three expect translat increment ebitda come
cross-sel opportun leverag custom base dd capabl
enhanc dd offer industry-lead tast capabl leverag direct
valuat dd segment reflect ebitda forecast project
slightli lower ev/ebitda multipl previous use sotp valuat
notabl impli remaind dd trade ebitda forecast view
attract multipl compani continu benefit combin activ portfolio
manag self-help initi on-going synergi realiz potenti rebound global economi
view on-going pfa litig suit separ legaci
dupont manag detail note litig risk appear manag regard
one-tim cash payment dd receiv upon transact close manag expect
util de-lev off-set ebitda leav compani portion
remain could util bolt-on dd note shareholder-friendli
remaind excess cash
dd re-affirmed adjust ep guidanc note
oper ebitda expect come toward low end rang due primarili
suppli chain disrupt safeti construct electron imag forecast ep
ebitda compar consensu lower ep
ebitda compar consensu
downward revis forecast reflect reduct electron imag
estim cut non-cor forecast larg account one-tim gain
expect repeat
arriv price target base
sum-of-the-part analysi ebitda impli blend multipl one could argu
multipl discount dd conglomer structur believ ed breen open
monet core segment offset
reduc dd price
dupont part analysi multipl enterpris valu peer electron imag entegri nutrit bioscienc rmt valuationtransport adv polym em victrex safeti construct discount blend dd average valu total minor prefer share price usdelectron imag imag bioscienc bioscienc adv polym adv polym construct construct dupont lower price decemb
incom goodwil impair asset relat charg separ earn nonconsolid affili incom expens amort debt loss cont op incom credit incom tax cont incom incom loss cont op avail dupont common per share per share average share average share sga/sal rate forma incom loss continu oper net tax vision credit incom tax continu oper forma incom loss continu oper incom tax incl merger-rel merger-rel interest incom interest expens amort debt discount non-oper pension/opeb benefit foreign exchang gain loss net cost histor alloc materi scienc ag adjust signific item benefit forma oper ebitda data electron imag bioscienc construct imag chg bioscienc chg industri chg construct chg chg revenu chg incl pre-tax equiti earn electron imag bioscienc construct margin electron imag bioscienc industri construct segment total earn electron imag bioscienc construct dupont lower price decemb
balanc note receiv current current intang incom tax charg due w/in one tax current current incom tax liabil postemploy non-current non-curr liabil work compens chang l-t asset invest invest lt financ dupont lower price decemb
statementpriornowdeltapriornowdeltanet earn nonconsolid affili incom expens amort debt continu tax provis continu incom incom continu op avail common per share per share average share average share sga/sal rate forma incom continu oper net vision credit incom tax continu oper forma incom loss continu oper incom tax interest incom interest expens amort debt discount non-oper pension/opeb benefit foreign exchang loss histor alloc materi scienc ag adjust signific forma oper ebitda dupont lower price decemb
margin ebitda mln electron imag ebitda ebitda marginsebitda mln ebitda margin ebitda mln transport industri ebitda ebitda marginsebitda mln ebitda marginsadvanc print solut electron imag revenu mln advanc printingdisplay interconnect solutionssemiconductor mobil solut specialti consum transport industri revenu mln mobil solutionshealthcar specialtyindustri consumersafeti solut solut solut safeti construct revenu mln safeti solutionsshelt solutionswat margin ebitda mln safeti construct ebitda ebitda marginsebitda mln ebitda margin dupont lower price decemb
margin ebitda mln nutrit bioscienc ebitda ebitda marginsebitda mln ebitda margin ebitda mln non-cor ebitda ebitda marginsebitda mln ebitda marginsadvanc print solut electron imag revenu mln advanc printingdisplay interconnect solutionssemiconductor food beverag bioscienc solut nutrit bioscienc revenu mln food beveragehealth biosciencespharma solut dupont lower price decemb
arriv price target base sum-of-the-part analysi ebitda impli
downsid risk price target includ exposur highli cyclic end market electron auto
construct volatil raw materi price translat risk fluctuat global currenc reduc
demand dollar-denomin product case dollar strengthen overal weak
prolong econom recess global market integr risk difficulti realiz synergi
carson herebi certifi view us express research report accur reflect respect person view subject
secur issuer also certifi part respect compens directli indirectli relat specif recommend view
express research report
sfg market maker secur dupont dd
susquehanna intern group llp compris number trade invest relat entiti common control includ susquehanna financi
group lllp sfg affili and/or princip may long short posit secur relat issu mention capac specialist and/
market maker may execut order princip basi subject secur inform present sourc believ reliabl guarante
accur complet past perform taken indic guarante futur result hyperlink provid report conveni pleas
awar product inform suppli hyperlink page endors approv sfg
follow data element report sourc bloomberg lp price yesterday close high low share outstand averag daili trade
volum volum contract other specif sourc
sfg employ follow rate system
posit expect stock appreci least next month
neutral expect stock perform within rang percentag point next month
neg expect stock depreci least next month
suspend previous publish rate and/or estim current suspend review
prior juli rate system also requir /- expect return month initi positive/neg rate
grossdebt preferredtev gross debt prefer total enterpris valu express
netdebt/ebitda net debt gross debt less cash hand ebitda forward year ebitda estim
yield yield fulli dilut share outstanding/curr share price express
ytm yield-to-matur ytm impli bond outstand due year closest express
us treasuri yield express
volum averag option contract volum symbol
skewrank current day skew valu compar past year worth skew valu rank current day valu past year calcul previou
trade day includ last trade day
impliedvolatil impli volatil at-the-forward volatil level impli market option price day impli volatil specif time frame
select alway present annual standard deviat
realizedvolatil realiz volatil financi instrument day gener measur calcul determin averag deviat
averag price financi instrument given time period measur frequent compar impli volatil determin option price over-
under-valued also known histor volatil
cover compani categori
proprietari sfg product prepar intend sole use sophist profession institut trader manag gener
invest public unauthor redistribut report mean repres violat us copyright law could result legal action suspens
intend recipi privileg question regard transmiss pleas contact inform commun
intend distribut use person entiti jurisdict countri distribut use would contrari law regul
would subject susquehanna financi group lllp affili registr requir within jurisdict countri
invest bank client categori
rate price target histori dupont dd
